Rachel K. King Insider Trading
Get free email notifications about insider trading for Rachel K. King.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rachel K. King. Rachel K. King is a Director in NOVAVAX INC ($NVAX) and a President, CEO in GLYCOMIMETICS INC ($GLYC).
Address: C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG 20879 MD
Companies in which Rachel K. King is an Insider
GLYCOMIMETICS INC
Trading Symbol: GLYCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rachel K. King: President, CEO
Holdings: 452,314 shares
Current Value: $2,831,486
Latest Transaction: Jan 22 2021
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVAVAX INC
Trading Symbol: NVAXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rachel K. King: Director
Holdings: 42,000 shares
Current Value: $55,020
Latest Transaction: Jun 26 2020
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Rachel K. King
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 22 2021 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | A | 3.81 | 192,500 | 733,425 | 192,500 | |
Jan 22 2021 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Grant | A | 0.00 | 96,250 | 0 | 452,314 | 356.1 K to 452.3 K (+27.03 %) |
Dec 30 2020 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | M | 1.12 | 130,821 | 146,520 | 0 | |
Dec 30 2020 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Sell | S | 3.91 | 84,176 | 329,128 | 356,064 | 440.2 K to 356.1 K (-19.12 %) |
Dec 30 2020 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Buy | M | 1.12 | 130,821 | 146,520 | 440,240 | 309.4 K to 440.2 K (+42.28 %) |
Jun 26 2020 | NVAX | NOVAVAX INC | King Rachel K. | Director | Option Exercise | A | 0.00 | 3,450 | 0 | 3,450 | |
Jun 26 2020 | NVAX | NOVAVAX INC | King Rachel K. | Director | Option Exercise | A | 83.54 | 6,900 | 576,426 | 6,900 |